EMCDDA Home
  • EN
Search

ENP project

The EMCDDA project targets 7 European Neighbourhood Policy (ENP) partner countries. These are: Armenia, Azerbaijan, Georgia, Israel, Moldova, Morocco and Ukraine.

Timetable: January 2014–June 2016

Objective: The overall objective of the EMCDDA-ENPI project is to strengthen the capacity of ENP Partner countries to react to new challenges and developments of the drugs situation.

In order to achieve this, the project has defined a set of measurable and specific objectives:

  • to support the partner countries to produce new information on their drugs situation;
  • to develop the capacity for monitoring;
  • to strengthen the reporting and dissemination of information.

Expected results are:

  • a better knowledge of recent and emerging trends in drug use in the partner ENP countries among young people;
  • the Early Warning System covers the new ENP partner countries for its ALERT component, which makes it more comprehensive and more accurate and enables effective exchange of information between EU member states and ENP countries;
  • increased capacity for data collection, analysis and interpretation in the ENP countries, as a result of the knowledge transfer facilitated by the project;
  • decision-makers at national and EU level are better informed on the drugs situation and on the need for interventions;
  • ENP partners and other Reitox members have a better knowledge and understanding of the drugs situation and of the role of drug monitoring.

2014 activities

  • Kick off meeting, 05-06 March 2014
  • The kick-off meeting of the EMCDDA–ENP (European Neighbourhood Policy) project took place at the EMCDDA headquarters, in Lisbon, Portugal, on 5–6 March 2014. The purpose of the meeting was: To introduce the members of the EMCDDA–ENP project team and to explain the role of the ENP national correspondent, to introduce and discuss the objectives of the project, to present the schedule of the project, to discuss and to agree on the programme of national and regional activities and to agree on a more specific and detailed calendar of activities for 2014 as well as on the roles and tasks of the EMCDDA and the partner countries.
    In total, six participants, representing Armenia, Azerbaijan, Georgia, Israel, Moldova and Ukraine attended the kick-off meeting.

  • Official visit of Prof. Jallal Toufiq, Head of the Moroccan drug observatory to EMCDDA, 14-15 April 2014
  • General Population Survey Indicator meeting attended by national experts of Georgia, Israel, Moldova and Morocco at EMCDDA, 17-18 June 2014
  • Georgia high level visit to EMCDDA, 24-25 June 2014
  • The Minister of Justice of Georgia, the Minister of Education of Georgia, the Deputy Minister of Internal Affairs of Georgia, the Head of the Mental health and Drug prevention Centre in the Ministry of Healthcare, the Deputy Head of Public International Law Department in the Ministry of Justice and the head of the NGO "Alternative Georgia" visited the EMCDDA on 24 June 2014

  • Visit to Morocco to contribute the drafting of the national report on the national drug situation, 1-2 July 2014
  • RTX Academy training course on ‘Contemporary approaches in drug monitoring' for ENP partner countries, in Prague, 8-12 September 2014
  • Main objective of the course: This five day training course gave professionals a grounding in organising a drug information system, collecting, analysing and interpreting drug-related data, and providing information on the drug situation that meets the needs of their different audiences.
    The course will help participants to respond to the following questions: (1) why drug monitoring and data collection is needed and what information is needed for various audiences; (2) how novel methods and academic research data could be used in the context of monitoring and analysing the drug situation.
    Target audience: The course was targeted towards professionals, researchers and administrators working at national drug monitoring bodies or persons closely linked to national activities aimed at consolidation of national drug monitoring systems in European Neighbourhood Policy countries. In total, 28 participants, representing Armenia (4 persons), Azerbaijan (1 person), Georgia (9 persons), Israel (4 persons), Moldova (3 persons), Morocco (2 persons) and Ukraine (5 persons), attended the course.

  • Reitox Academy on ‘Drug related expenditures’ in Israel, 30/09-02/10/2014
  • This Reitox Academy was organised in close cooperation with the Israel Anti-Drug Authority (IADA). The objectives were to better understand the EMCDDA role within and beyond the European Union and its data collection mechanisms and tools; to better understand drug-related public expenditure; to share good practices in estimating costs of Opioid Substitution Treatment in some European countries; to develop a roadmap to estimate drug-related public expenditures in Israel.
    Target audience The course gathered, 33 Israeli experts, representing IADA, the Israel National Institute for Health Policy Research, the Israel Police, the Brookedale Institute, the Ben Gurion University of the Negav, the Ministries of Public Security, Health, Social Affairs and Social Services, Education, Justice, the National Insurance Institute of Israel, the Israel prison service, the Israel National Road Safety Authority and the Hebrew University of Jerusalem, attended the course.

  • Technical visit to Moldova, 6-10-10/2014, technical visit to Georgia, 20-24 October 2014
  • The objective of these visits was to present the EMCDDA and its activities, to present the project and its planned training activities as well as to identify potential partners in terms of drugs data collection and monitoring in the future. EMCDDA staff met with representatives from different Ministries, NGOs, prison administration, treatment centres etc…

  • Reitox Academy on ‘The European Union, the EU drugs policy and the relations with European Neighbourhood Policy partner countries, 28-29 October 2014
  • Main objective of the Academy The objective of the Academy was to provide participants with an overview on how the EU governs its cooperation with the ENP countries in general and on drug-related issues in particular. The participants also learnt how drug-related issues are addressed within the framework of EU institutions and policies, and gained knowledge on the various funding mechanisms available through the EU to support the development of national drug monitoring systems in the ENP region.

  • Reitox Week, 24-25 November 2014

 

Page last updated: Friday, 13 November 2015